@article{b828c95463874bbca7a8e016a4c92dff,
title = "Aging and diabetes: Shifting the risk trajectory with high-sensitivity cardiac troponins",
author = "Neeland, {Ian J.} and {de Lemos}, {James A.}",
note = "Funding Information: Funding. I.J.N. is supported by National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK106520 and by the Dedman Family Scholarship in Clinical Care from UT Southwestern. Duality of Interest. I.J.N. reports being an investigator on a trial of liraglutide (Novo Nordisk) for obesity and being a former speaker/ consultant for Boehringer Ingelheim/Lilly Alliance. J.A.d.L. has received grant support from Roche Diagnostics and Abbott Diagnostics, honoraria from participation in data and safety monitoring board committees from Novo Nordisk and Eli Lilly, and consulting income from Ortho Clinical Diagnostics. He has been named as a co-inventor on a patent issued to the University of Maryland (U.S. patent application number 15/309754) titled “Methods for Assessing Differential Risk for Developing Heart",
year = "2020",
month = jun,
day = "1",
doi = "10.2337/dci20-0009",
language = "English (US)",
volume = "43",
pages = "1172--1174",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "6",
}